Form 8-K - Current report:
SEC Accession No. 0000882095-24-000003
Filing Date
2024-02-06
Accepted
2024-02-06 16:04:07
Documents
16
Period of Report
2024-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20240206.htm   iXBRL 8-K 32649
2 EXHIBIT 99.1 exhibit991earningspressrel.htm EX-99.1 733574
6 LOGO gilead_transparentxlogoxst.jpg GRAPHIC 37853
  Complete submission text file 0000882095-24-000003.txt   986840

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20240206.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20240206_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20240206_pre.xml EX-101.PRE 12521
17 EXTRACTED XBRL INSTANCE DOCUMENT gild-20240206_htm.xml XML 2911
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 24600191
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)